Artificial liver ‘boosts survival in acute liver failure patients’
June 3rd, 2009 - 12:21 pm ICT by ANIWashington, June 3 (ANI): Scientists from NewYork-Presbyterian Hospital and Columbia University Medical Centre have developed what they call ‘artificial liver’- an innovative device that will help improve survival in patients with acute liver failure.
The device called Extracorporeal Liver Assist Device, or ELAD uses immortalized human liver cells.
It is a bedside system that treats blood plasma, metabolizing toxins and synthesizing proteins just like a real liver does.
“These studies are looking at how well the system can extend patients’ lives until a liver transplant becomes available,” said Dr. Robert Brown, director of the Centre for Liver Disease and Transplantation at NewYork-Presbyterian Hospital/Columbia University Medical Centre.
“We’re also interested to see if it can relieve the burden on the patient’s liver enough so that it can regenerate and regain some of its function,” he added.
The ongoing studies look at whether ELAD liver support improves survival compared with standard medical therapy.
Patients are randomly assigned to receive either standard medical therapy plus the ELAD system, or standard medical therapy alone.
Another trial open to patients with liver failure due to drug overdose without underlying liver disease is expected to begin enrollment later this year.
With the ELAD system manufactured by Vital Therapies Inc. of San Diego, four 12-inch cartridges containing cells derived from human liver cells and fibers are mounted on a standard blood-pumping unit.
The patient’s blood plasma flows inside of hollow fibres to allow appropriate two-way transfer of metabolites across the fibre membrane. (ANI)
- First 3 patients fitted with next-generation mechanical heart pumps in US - Jun 03, 2009
- Bionic eye restores partial vision in US woman - Oct 22, 2009
- New robotic devices to give stroke patients a helping hand, leg up - Jun 19, 2010
- Stem cells from skin, blood regenerate faltering liver - May 12, 2011
- Ability to predict stroke recovery vital for survivors and their families - Jun 25, 2010
- Healthy liver-cell transplants may help treat genetic liver-lung disorder - Apr 23, 2011
- Bionic 'eye' restores partial vision in woman - Oct 22, 2009
- Delhi doctors save two-year-old girl - Mar 14, 2012
- Iraqi woman gets new life with bone marrow transplant in India - Sep 23, 2010
- Gene therapy for heart failure patients shows promising results in phase I trial - Nov 11, 2008
- New laser technology may reduce prostate surgery's sexual side effects - Aug 06, 2010
- Stem cells may help treat aggressive multiple sclerosis - Mar 22, 2011
- Bariatric surgery cuts long-term cardiovascular risk in diabetics - Mar 31, 2011
- Everolimus-eluting stent safer, more effective than paclitaxel-eluting stent - May 06, 2010
- Scientists grow human liver tissue for transplantation - Jan 21, 2011
Tags: acute liver failure, acute liver failure patients, artificial liver, blood plasma, columbia university medical, dr robert, drug overdose, elad, fibers, fibres, human liver cells, june 3, liver disease, liver failure patients, liver support, liver transplant, medical therapy, metabolites, presbyterian hospital, university medical centre
